![Stuart Gunzburg](/sites/default/files/styles/medium/public/bn-di-person/Stuart%20Gunzburg.png?itok=0aEdPRDg)
Stuart Gunzburg
Dr Stuart Gunzburg has an extensive background in medical research. He has been involved in several startup ventures covering a diverse range of applications including anti-cancer drug development, renewable fuel production, waste management system developments and technology applications in the explosives industry.
Dr Gunzburg is the executive director and chief scientist of Virex Pharma. His work on the nano-emulsion drug delivery technology is the foundation of the company’s GlyXine© anti-viral drug formulation.